New Delhi, Apr 6: The Serum Institute of India (SII) will start supplying the first indigenously developed pneumococcal conjugate vaccine to the Centre from Wednesday, sources said on Tuesday. The vaccine acts against potentially fatal pneumococcal infections such as pneumonia, septicaemia